HCRT and myeloid sarcoma: As suppressed butyrate production raises ceramide levels and lowers levels of ceramide conversion to gangliosides, thereby suppressing orexin and contributing to suboptimal mitochondria functioning, the gut has emerged as an important hub for modulating and synchronizing many of the changes associated with MS pathophysiology.